Advisor Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $14.4M | Buy |
44,517
+2,328
| +6% | +$699K | 1.02% | 11 |
|
|
2022
Q1 | $12.1M | Sell |
42,189
-266
| -0.6% | -$68.5K | 0.76% | 17 |
|
|
2021
Q4 | $11.7M | Buy |
42,455
+665
| +2% | +$169K | 0.71% | 18 |
|
|
2021
Q3 | $9.65M | Sell |
41,790
-444
| -1% | -$110K | 0.65% | 28 |
|
|
2021
Q2 | $9.69M | Buy |
42,234
+565
| +1% | +$113K | 0.64% | 25 |
|
|
2021
Q1 | $7.79M | Sell |
41,669
-2,124
| -5% | -$415K | 0.56% | 34 |
|
|
2020
Q4 | $7.39M | Sell |
43,793
-3,634
| -8% | -$543K | 0.56% | 35 |
|
|
2020
Q3 | $7.02M | Sell |
47,427
-1,830
| -4% | -$283K | 0.6% | 35 |
|
|
2020
Q2 | $8.09M | Buy |
49,257
+2,257
| +5% | +$346K | 0.75% | 25 |
|
|
2020
Q1 | $6.52M | Buy |
47,000
+11,570
| +33% | +$1.59M | 0.79% | 25 |
|
|
2019
Q4 | $5M | Buy |
35,430
+4,078
| +13% | +$473K | 0.52% | 42 |
|
|
2019
Q3 | $3.51M | Buy |
31,352
+810
| +3% | +$90.2K | 0.42% | 48 |
|
|
2019
Q2 | $3.38M | Buy |
30,542
+466
| +2% | +$54.9K | 0.41% | 45 |
|
|
2019
Q1 | $3.9M | Sell |
30,076
-946
| -3% | -$115K | 0.5% | 40 |
|
|
2018
Q4 | $3.59M | Buy |
31,022
+5,019
| +19% | +$561K | 0.57% | 36 |
|
|
2018
Q3 | $2.79M | Buy |
26,003
+893
| +4% | +$89.3K | 0.38% | 51 |
|
|
2018
Q2 | $2.14M | Buy |
25,110
+2,968
| +13% | +$244K | 0.36% | 56 |
|
|
2018
Q1 | $1.71M | Sell |
22,142
-1,178
| -5% | -$94.8K | 0.32% | 68 |
|
|
2017
Q4 | $1.99M | Buy |
23,320
+2,666
| +13% | +$227K | 0.36% | 56 |
|
|
2017
Q3 | $1.77M | Sell |
20,654
-40
| -0.2% | -$3.28K | 0.35% | 59 |
|
|
2017
Q2 | $1.7M | Buy |
20,694
+1,540
| +8% | +$126K | 0.4% | 53 |
|
|
2017
Q1 | $1.61M | Buy |
19,154
+4,591
| +32% | +$368K | 0.43% | 50 |
|
|
2016
Q4 | $1.07M | Sell |
14,563
-2,286
| -14% | -$170K | 0.32% | 78 |
|
|
2016
Q3 | $1.35M | Sell |
16,849
-1,040
| -6% | -$83.2K | 0.45% | 51 |
|
|
2016
Q2 | $1.41M | Buy |
17,889
+2,055
| +13% | +$155K | 0.49% | 51 |
|
|
2016
Q1 | $1.14M | Sell |
15,834
-7,827
| -33% | -$592K | 0.42% | 59 |
|
|
2015
Q4 | $1.99M | Buy |
23,661
+4,448
| +23% | +$369K | 0.68% | 38 |
|
|
2015
Q3 | $1.61M | Buy |
19,213
+1,538
| +9% | +$130K | 0.67% | 35 |
|
|
2015
Q2 | $1.34M | Buy |
17,675
+2,699
| +18% | +$206K | 0.51% | 50 |
|
|
2015
Q1 | $1.09M | Buy |
14,976
+1,074
| +8% | +$76.5K | 0.46% | 55 |
|
|
2014
Q4 | $952K | Buy |
13,902
+265
| +2% | +$17.9K | 0.42% | 69 |
|
|
2014
Q3 | $884K | Buy |
13,637
+243
| +2% | +$15.4K | 0.51% | 52 |
|
|
2014
Q2 | $833K | Buy |
13,394
+1,512
| +13% | +$90.2K | 0.41% | 67 |
|
|
2014
Q1 | $699K | Buy |
11,882
+519
| +5% | +$29K | 0.38% | 76 |
|
|
2013
Q4 | $580K | Buy |
11,363
+328
| +3% | +$16.4K | 0.33% | 95 |
|
|
2013
Q3 | $555K | Buy |
11,035
+1,055
| +11% | +$55.2K | 0.4% | 85 |
|
|
2013
Q2 | $490K | Buy |
+9,980
| New | +$543K | 0.4% | 86 |
|
Other funds holding LLY
Advisor Partners's LLY Position: Q2 2022 in Review
Advisor Partners increased its Eli Lilly (LLY) stake by 5.5% in Q2 2022, buying an estimated $699K and bringing the position to 44,517 shares worth $14.4M. The position accounts for 1.02% of the portfolio, ranked #11.
Advisor Partners first reported a position in LLY in Q2 2013 and has held it in 37 quarters since. 2,446 funds tracked by Wall St. Rank hold LLY as of Q2 2022.
- Advisor Partners held 44,517 shares of Eli Lilly worth $14.4M as of Q2 2022.
- Advisor Partners bought 2,328 Eli Lilly shares in Q2 2022, an estimated $699K.
- Eli Lilly made up 1.02% of Advisor Partners's portfolio in Q2 2022, its #11 holding.
- Advisor Partners first reported a position in Eli Lilly in Q2 2013 and has held it in 37 quarters since.
- 2,446 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2022.
Based on Advisor Partners's 13F filing for Q2 2022, filed 11 Aug 2022.